Dr. Sara Michell Tolaney MD
Hematologist-Oncologist | Hematology & Oncology
55 Fruit Street Yaw 7604 Massachusetts Genera Boston MA, 02114About
Dr. Tolaney received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at J ...
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
- Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor.
- Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.
- The evolving understanding of small HER2-positive breast cancers: matching management to outcomes.
- Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer.
- Optimal Management of Early and Advanced HER2 Breast Cancer.
- Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.
- Occurrence and significance of morphologic changes in patients with metastatic triple negative breast cancer treated with Cabozantinib.
- Efficacy and safety in older patient subsets in studies of endocrine monotherapy versus combination therapy in patients with HR+/HER2- advanced breast cancer: a review.
Clinical Trials
- Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer
- PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
- A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer
- Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
- Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
- A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer
- A Study Of Pembrolizumab In Combination With Trastuzumab-DM1
- CISPLATIN + AZD-1775 In Breast Cancer
- A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
- Palbociclib With Everolimus + Exemestane In BC
- Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer
- A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
- An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.
- A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
- Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
- A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Awards
- Phi Beta Kappa Princeton University 1998
- Alpha Omega Alpha 2002
Fellowships
- Dana-Farber/Partners CancerCare
- Dana Farber Cancer Institute, Fellow 2005
Dr. Sara Michell Tolaney MD's Practice location
Dr. Sara Michell Tolaney MD's reviews
Write ReviewPatient Experience with Dr. Tolaney
Recommended Articles
- How to Deal with Lymphoma Treatment Fatigue
Treatment fatigue is a very common problem among lymphoma patients. Whether the patient is doing pharmaceutical treatments, chemotherapy, or other treatments, they will likely lead to fatigue and a feeling of being burnt out.This article will go over what treatment fatigue is, symptoms that are...
- Treatments for Multiple Myeloma
The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...
- Life Lessons After Multiple Misdiagnoses of Lymphoma
28-year-old Jessica DeCristofaro had been coughing persistently and she was told by her doctor that it was a result of allergies. She even took medication for her supposed allergies over the course of two years. When the medication failed to improve her persistent cough, another doctor diagnosed her...
- Living as a Hodgkin Lymphoma Survivor: Creating a New Normal
No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...
- Arizona Firefighters Raise Funds for Lymphoma Stairclimb
Jackson County Fire District #5 partnered with Dutch Bros. Coffee in Phoenix, Arizona to help raise funds for the Leukemia & Lymphoma Society’s Scott Firefighter Stairclimb in Seattle, which took place at the Columbia Center on March 11th, 2018. All of the money raised for the stairclimb go to...
- Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a Cause
Everyone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...
Nearby Providers
- Dr. YongLi Ji M.D. , PH.D.55 Fruit St Boston MA 02114
- Dr. John Erban MD55 Fruit Street Boston MA 02114
- Dr. Matthew D Hellmann MDMassachusetts General Hospital Boston MA 02114
- Dr. Nathan A Pennell MD PHD55 Fruit St Boston MA 02114
- Dr. Matthew L. Ulrickson M.D.Massachusetts General Hospital Boston MA 02114
- Dr. David R Spriggs MD55 FRUIT ST BOSTON MA 02114